BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13973459)

  • 1. [Clinico-biological considerations on a case of Wilson's disease with normal ceruloplasmin levels].
    REBUCCI GG; TASSINARI CA
    Riv Patol Nerv Ment; 1962 Sep; 83():498-518. PubMed ID: 13973459
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 3. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
    BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
    Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
    [No Abstract]   [Full Text] [Related]  

  • 6. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 7. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic aspects of Wilson's disease: a review.
    SIMPSON JF
    Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
    [No Abstract]   [Full Text] [Related]  

  • 10. Wilson's disease and the concentration of caeruloplasmin in serum.
    SCHEINBERG IH; STERNLIEB I
    Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
    [No Abstract]   [Full Text] [Related]  

  • 11. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
    HELLER GL
    Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
    [No Abstract]   [Full Text] [Related]  

  • 12. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
    BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
    Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
    [No Abstract]   [Full Text] [Related]  

  • 13. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
    RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
    Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
    [No Abstract]   [Full Text] [Related]  

  • 16. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
    J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 19. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.